Study to Assess the Safety and Efficacy of Enbrel Administered by Sofusa DoseConnect for Rheumatoid Arthritis
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
This is an open-label pilot study in patients with rheumatoid arthritis (RA). All patients
will receive SOFUSA Enbrel 25 mg once weekly. The dose will be increased to 50 mg if the dose
escalation criteria are met during the dose escalation phase of the study.